• Mashup Score: 0

    July 12, 2023 — CPR Therapeutics Inc. (CPR-T), a Vermont-based medical device start-up company, announced today that it has received three U.S. patents for inventions that will contribute to the development of their breakthrough technology for cardiopulmonary resuscitation. The first patent (US11,684,542) is for CPR devices that use more than one type of compression pattern to increase blood flow…

    Tweet Tweets with this article
    • @DAICeditor #CPRTherapeutics Inc. announced that it has received three U.S. #patents for #inventions that will contribute to the development of their #breakthrough #technology for #cardiopulmonary #resuscitation: https://t.co/TlZub69umv

  • Mashup Score: 0

    A novel chimeric antigen receptor T-cell therapy induced clinically impactful antitumor responses in 63% of younger patients with relapsed or refractory, high-risk neuroblastoma, results of a phase 1/phase 2 trial showed.The findings, published in The New England Journal of Medicine, suggest the investigational agent also has a manageable safety profile similar to other CAR T-cell therapies,

    Tweet Tweets with this article
    • #Breakthrough Study shows ‘CAR T CELLS CAN ERADICATE SOLID TUMORS in advanced neuroblastoma. https://t.co/5NuYCbYJz0 #CellTherapyNext #HemOnc #OncAlert #MedEd @Unicatt @Stanford #neuroblastoma